VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics based on a novel AAV gene therapy platform, antibody-based targeted protein degradation technologies and proprietary manufacturing technology.

While focusing initially on neurodegenerative diseases, the Dutch company's synergistic technologies may be applied across a wide range of indications.